Drug Testing and Analysis最新文献

筛选
英文 中文
Emerging Interest in SLU-PP-332: Implications for Public Health and Doping Control. 对SLU-PP-332的新兴趣:对公共卫生和兴奋剂控制的影响。
IF 2.6 3区 医学
Drug Testing and Analysis Pub Date : 2026-11-16 DOI: 10.1002/dta.70196
Ilaria Palmi, Simona Pichini, Renata Solimini
{"title":"Emerging Interest in SLU-PP-332: Implications for Public Health and Doping Control.","authors":"Ilaria Palmi, Simona Pichini, Renata Solimini","doi":"10.1002/dta.70196","DOIUrl":"https://doi.org/10.1002/dta.70196","url":null,"abstract":"","PeriodicalId":160,"journal":{"name":"Drug Testing and Analysis","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149416672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of Micro Capillary Blood for Use in the Athlete Biological Passport. 运动员生物护照用微细血管血液的验证。
IF 2.6 3区 医学
Drug Testing and Analysis Pub Date : 2026-11-14 DOI: 10.1002/dta.70188
Laura Lewis, Jakob Morkeberg, Jenna Goodrum, Lasse Baekken, Yvette Dehnes, Geoff Miller
{"title":"Validation of Micro Capillary Blood for Use in the Athlete Biological Passport.","authors":"Laura Lewis, Jakob Morkeberg, Jenna Goodrum, Lasse Baekken, Yvette Dehnes, Geoff Miller","doi":"10.1002/dta.70188","DOIUrl":"https://doi.org/10.1002/dta.70188","url":null,"abstract":"<p><p>Anti-doping sample collection and analysis have evolved since the introduction of the first World Anti-Doping Code. Most of the changes introduced by revisions to the Code have focused on analysis rather than sample collection methods. Changes to collection methods have the potential to impact pre-analytical and/or analytical variance. Therefore, validation of capillary collection devices is important to the integrity and success of the athlete biological passport (ABP). Paired capillary and venous samples (n = 220) were collected from athletes during out-of-competition (OOC) tests and analyzed for ABP markers. Data from the OOC trial were pooled with previous data collected under laboratory conditions and during an in-competition setting. Across the pooled dataset (n = 300), capillary and venous measurements showed strong agreement for the primary ABP markers. Deming regression supported close alignment between methods, with slopes near 1.0 and intercepts near 0. Bland-Altman analysis indicated minimal bias and no evidence of systematic divergence across the observed measurement ranges. ABP profiles were created for 19 athletes who contributed more than one set of paired samples to the dataset. When inserted into ABP profiles, differences between capillary and venous blood had minimal impact on upper and lower limits of the adaptive model. Capillary blood collection is a valid and interchangeable method of blood collection for ABP purposes and presents a significant advancement in athlete-centered anti-doping protocols. The introduction of the 2027 Code and International Standards paves the way for implementation of an optimal anti-doping experience for athletes without compromising scientific integrity.</p>","PeriodicalId":160,"journal":{"name":"Drug Testing and Analysis","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149400442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quantitative Analysis of Lysergic Acid Diethylamide: A Ring Study Among Five Swiss Drug Checking Services. 麦角酸二乙胺的定量分析:瑞士五家药品检测机构的环形研究。
IF 2.6 3区 医学
Drug Testing and Analysis Pub Date : 2026-11-14 DOI: 10.1002/dta.70190
Manuela Carla Monti, Emilia Gianola, Raoul P J Koning, Mireia Ventura, Pieter E Oomen
{"title":"Quantitative Analysis of Lysergic Acid Diethylamide: A Ring Study Among Five Swiss Drug Checking Services.","authors":"Manuela Carla Monti, Emilia Gianola, Raoul P J Koning, Mireia Ventura, Pieter E Oomen","doi":"10.1002/dta.70190","DOIUrl":"https://doi.org/10.1002/dta.70190","url":null,"abstract":"<p><p>Lysergic acid diethylamide (LSD) is a serotonergic psychedelic with active dosages in the microgram range. Accurate information about the LSD content of blotters is essential for harm reduction. However, drug checking services (DCS) across Europe have reported that service users expect LSD contents to be considerably higher than what is measured analytically, raising questions about the accuracy and reliability of current methods used in DCS settings. This study presents an interlaboratory ring trial on LSD quantification within the context of drug checking. Five Swiss DCS laboratories participated, each employing different analytical techniques (HPLC-DAD, GC-MS, and HPLC-MS/MS) and extraction procedures. Three sample types were distributed: two LSD-infused blotters and one methanolic LSD solution. The quantitative results were corrected based on purity determined by proton nuclear magnetic resonance spectroscopy (qNMR) of the reference standard. Interlaboratory variability was low, with relative standard deviations of 8%-16.5% and mean accuracy ranging from -5.3% to -13.0%. Variability was higher for the liquid sample. The largest deviations were reported for mass spectrometry-based methods. The study confirmed the reliability of LSD quantification across participating DCS laboratories. Additional factors that could potentially contribute to the reported discrepancy were discussed: limited stability of LSD, potential inconsistencies in clandestine blotter production methods, and user expectations shaped by marketing or anecdotal reports. The findings support the accuracy of current LSD quantification methods in drug checking settings and provide a foundation for future proficiency testing. Reliable chemical data is essential for accurate dosing and effective harm reduction.</p>","PeriodicalId":160,"journal":{"name":"Drug Testing and Analysis","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149400441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diclofenac in Urine Samples Deactivates the GC/C/IRMS Reactor and Compromises the Determination of δ13C Values of Steroids. 尿液样本中的双氯芬酸使GC/C/IRMS反应器失活并影响类固醇δ13C值的测定。
IF 2.6 3区 医学
Drug Testing and Analysis Pub Date : 2026-11-13 DOI: 10.1002/dta.70179
Yan Mengmeng, Wen Chao, Yan Kuan, Zhu Tianshuo, Ma Congcong, Wang Zhanliang
{"title":"Diclofenac in Urine Samples Deactivates the GC/C/IRMS Reactor and Compromises the Determination of δ<sup>13</sup>C Values of Steroids.","authors":"Yan Mengmeng, Wen Chao, Yan Kuan, Zhu Tianshuo, Ma Congcong, Wang Zhanliang","doi":"10.1002/dta.70179","DOIUrl":"https://doi.org/10.1002/dta.70179","url":null,"abstract":"<p><p>Gas chromatography/combustion/isotope ratio mass spectrometry (GC/C/IRMS) is used as a confirmation procedure for detecting the administration of synthetic forms of endogenous anabolic androgenic steroids (EAAS) by comparing the carbon isotope ratios (δ<sup>13</sup>C) of target compounds (TCs) with those of endogenous reference compounds (ERCs). In recent years, some samples have been found to still contain interfering matrix components in different TC/ERC fractions after HPLC purification, which can rapidly deactivate the GC/C/IRMS reactor. 1-(2,6-Dichlorophenyl)indolin-2-one (1-(DCP)I) has been identified as a major contributor to reactor deactivation. Subsequent studies suggested that 1-(DCP)I was associated with diclofenac (DCF), a major metabolite formed following DCF sodium administration. DCF can persist in target fractions even after purification by one- or two-dimensional semipreparative liquid chromatography coupled with fraction collection. During subsequent GC/C/IRMS analysis, residual chlorinated substances in purified fractions may contribute to oxidation reactor deactivation, thereby interfering with the determination of analyte 's δ<sup>13</sup>C values. Optimization of the backflush time in the GC/C/IRMS system can effectively minimize the influence of these chlorine-containing substances on analysis.</p>","PeriodicalId":160,"journal":{"name":"Drug Testing and Analysis","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149400440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detecting GHRH Analogue Tesamorelin and Its Metabolites in Post-Administration Human Urine and Serum Using LC-HRMS/MS. 用LC-HRMS/MS检测GHRH类似物替沙莫林及其在给药后人尿和血清中的代谢物。
IF 2.6 3区 医学
Drug Testing and Analysis Pub Date : 2026-11-11 DOI: 10.1002/dta.70189
T Colpaert, G Miller, J Goodrum, V Nair, A Crouch, P Van Eenoo, K Deventer
{"title":"Detecting GHRH Analogue Tesamorelin and Its Metabolites in Post-Administration Human Urine and Serum Using LC-HRMS/MS.","authors":"T Colpaert, G Miller, J Goodrum, V Nair, A Crouch, P Van Eenoo, K Deventer","doi":"10.1002/dta.70189","DOIUrl":"https://doi.org/10.1002/dta.70189","url":null,"abstract":"<p><p>Tesamorelin is a growth hormone-releasing hormone (GHRH) analogue used for reducing excess abdominal fat in HIV-infected patients suffering from lipodystrophy. Together with other GHRH analogues, it is classified as a doping agent and is prohibited at all times according to the World Anti-Doping Agency (WADA). To investigate whether current testing methodologies are adequate for detecting tesamorelin abuse, an administration study was performed involving six healthy volunteers and 10 consecutive days of Egrifta (tesamorelin) injections, mimicking a doping protocol. A validated solid-phase extraction method was used to analyse the samples, reaching limits of detection of 13 pg/mL in urine and 41 pg/mL in serum. To account for the generation of metabolites by proteolytic degradation, tesamorelin was incubated in fresh human serum. Five previously unreported metabolites were found and identified, extending the detectability of tesamorelin abuse. Oxidation of the methionine residue was observed in tesamorelin and metabolites, hence ions to monitor the sulfoxide and sulfone forms were added to the methods. Despite a limit of detection 70 times lower than the WADA minimum required performance level and the inclusion of several metabolites, tesamorelin use could not be detected in post-administration urine. In serum, tesamorelin metabolites were detected in all six volunteers for up to 2 h after injection, whereas intact tesamorelin was detected in just two volunteers, up to 30 min post-administration. The outcome of this study shows that tesamorelin has a short detection window and testing methods should focus on metabolites in serum, rather than intact compounds in urine.</p>","PeriodicalId":160,"journal":{"name":"Drug Testing and Analysis","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149392192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mutant Human Erythropoietin from Insect Cells as Novel Low Molecular-Weight Internal Standards for ERAs Analysis. 从昆虫细胞中提取的人促红细胞生成素突变体作为一种新型的低分子量内标进行era分析。
IF 2.6 3区 医学
Drug Testing and Analysis Pub Date : 2026-11-09 DOI: 10.1002/dta.70187
Chengshuai Niu, Junhan Mao, Sen He, Xinchao Liu, Xinmiao Zhou
{"title":"Mutant Human Erythropoietin from Insect Cells as Novel Low Molecular-Weight Internal Standards for ERAs Analysis.","authors":"Chengshuai Niu, Junhan Mao, Sen He, Xinchao Liu, Xinmiao Zhou","doi":"10.1002/dta.70187","DOIUrl":"https://doi.org/10.1002/dta.70187","url":null,"abstract":"<p><p>Doping analysis of erythropoietin receptor agonists (ERAs) is frequently hindered by the \"no band\" phenomenon, in which endogenous erythropoietin (EPO) becomes undetectable owing to a variety of pre-analytical factors. The absence of an internal standard (ISTD) poses the risk of an undetected sample preparation failure. Furthermore, the EPO gene variant c.577del presents a substantial analytical challenge. Specifically, the failure to identify variant-encoded EPO (VAR-EPO) during reverse immunopurification (RI) may cause false-positive results for recombinant EPO (rEPO), highlighting the necessity of an ISTD for RI process monitoring. Nevertheless, the degradation of high molecular weight PEG-modified ISTDs could interfere with ERAs detection. To address these technical limitations, low molecular weight ISTDs represent a superior alternative for methodological development. This study reports the strategic development of two novel low molecular weight ISTDs: a wild-type EPO-based designed mutant (INS1) and a mutant EPO encoded by the c.557del variant (INS2). Both mutant proteins were expressed in the H5 insect cell line via the baculovirus expression vector system. The two engineered EPO mutants possess simplified paucimannose-type N-glycans, conferring a distinctly lower molecular weight profile than endogenous EPO and mammalian cell-expressed rEPO. Functionally, INS1 is designed to monitor the integrity of the initial testing procedure (ITP), whereas INS2 is engineered for process monitoring of RI to enable accurate rEPO confirmation. The results demonstrate that the developed low molecular weight ISTDs can effectively monitor procedural integrity and improve the detection performance of ERAs analytical assays.</p>","PeriodicalId":160,"journal":{"name":"Drug Testing and Analysis","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Vivo Metabolic Profiling of Suzetrigine in Thoroughbred Horses Following Oral Administration: Implications for Equine Anti-Doping Control. 纯种马口服suzetriine的体内代谢分析:对马的反兴奋剂控制的影响。
IF 2.6 3区 医学
Drug Testing and Analysis Pub Date : 2026-11-07 DOI: 10.1002/dta.70186
Michael Benedict Subhahar, Moses Philip, Fatma Ibrahim Alhammadi, Tajudheen K Karatt, Samir Meissir, Zubair Perwad, Fatma Mohammed Graiban, Shino Ann Koshy, Meleparappil Muhammed Ajeebsanu, Abdul Khader Karakka Kal
{"title":"In Vivo Metabolic Profiling of Suzetrigine in Thoroughbred Horses Following Oral Administration: Implications for Equine Anti-Doping Control.","authors":"Michael Benedict Subhahar, Moses Philip, Fatma Ibrahim Alhammadi, Tajudheen K Karatt, Samir Meissir, Zubair Perwad, Fatma Mohammed Graiban, Shino Ann Koshy, Meleparappil Muhammed Ajeebsanu, Abdul Khader Karakka Kal","doi":"10.1002/dta.70186","DOIUrl":"https://doi.org/10.1002/dta.70186","url":null,"abstract":"<p><p>Suzetrigine (VX-548), a selective NaV1.8 sodium channel blocker recently approved for pain management, was investigated for its metabolic fate in Thoroughbred horses using liquid chromatography coupled to high-resolution mass spectrometry (LC-HRMS). Equine urine and plasma samples were collected following administration and processed prior to analysis. Combining the present in vivo data with earlier reported in vitro liver incubations, a total of 12 metabolites (M1-M12) were identified and characterised, comprising nine Phase I and three Phase II biotransformation products. Five Phase I metabolites (M1-M4 and M9) were detected in vivo, formed through O-demethylation, C-demethylation, monohydroxylation, and hydrolysis of the amide function. Four further Phase I metabolites (M5-M8), previously reported by our team, were observed solely in in vitro liver incubations and were not detected in any in vivo sample. Phase II metabolism yielded three conjugated metabolites, comprising two glycosidation products (M10 and M11) detected in both urine and plasma, and one sulfonate conjugate (M12) confined to urine. Intact suzetrigine was the most abundant plasma analyte at every sampling point, followed by the O-demethylated metabolite M1, whereas in urine, the amide hydrolysis product M9 was overwhelmingly dominant and the parent drug accounted for less than 1% of its response. Intact suzetrigine remained detectable in plasma throughout a 192-h period, while M1 and M9 persisted in urine to the final sampling points. These findings define the metabolic disposition of suzetrigine in the horse and identify M9 and M1 as the most suitable analytical targets for the detection of suzetrigine misuse in equine doping control.</p>","PeriodicalId":160,"journal":{"name":"Drug Testing and Analysis","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149369746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detection of Lower Molecular Mass Peptides, Steroid Esters, and Multi-Class Substances in a Single Dried Blood Spot for Comprehensive Initial Testing in Doping Control. 在单一干血点中检测低分子质量多肽、类固醇酯和多类物质用于兴奋剂控制的综合初始检测。
IF 2.6 3区 医学
Drug Testing and Analysis Pub Date : 2026-11-05 DOI: 10.1002/dta.70184
Panagiotis Sakellariou, Andreas Thomas, Jasmin Thelen, Mario Thevis
{"title":"Detection of Lower Molecular Mass Peptides, Steroid Esters, and Multi-Class Substances in a Single Dried Blood Spot for Comprehensive Initial Testing in Doping Control.","authors":"Panagiotis Sakellariou, Andreas Thomas, Jasmin Thelen, Mario Thevis","doi":"10.1002/dta.70184","DOIUrl":"https://doi.org/10.1002/dta.70184","url":null,"abstract":"<p><p>Dried blood spots (DBS) have become an increasingly important matrix in anti-doping testing, providing, among other advantages, direct access to circulating parent compounds. However, the limited amount of blood available from a single DBS represents a considerable analytical challenge, particularly following the inclusion of lower molecular mass peptides into the current World Anti-Doping Agency (WADA) guidelines for DBS testing. Existing analytical methods are primarily dedicated to peptide analysis and do not address the simultaneous detection of other prohibited substances within routine anti-doping workflows. The aim of the present study was to develop and validate a comprehensive LC-HRMS/MS workflow for the simultaneous detection of lower molecular mass peptides, anabolic steroid esters, and prohibited non-threshold substances without minimum reporting level (MRL) from a single DBS, collected on both Tasso-M20 devices and cellulose-based DMPK-C cards. Method validation was performed according to current WADA requirements for initial testing procedures and included the evaluation of selectivity, reliability, limits of detection, extract stability, carryover, and robustness. The developed method fulfilled all validation criteria for both DBS collection devices and enabled the sensitive detection of all investigated intact peptides together with steroid esters and multi-class prohibited substances. The presented workflow enables, for the first time, the simultaneous detection of lower molecular mass peptides, steroid esters, and multi-class prohibited substances from a single DBS spot. This integrated approach reduces sample consumption, simplifies laboratory workflows, and preserves additional DBS material for confirmatory or complementary analyses, providing a practical and flexible strategy for routine DBS anti-doping testing.</p>","PeriodicalId":160,"journal":{"name":"Drug Testing and Analysis","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149339998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Caps Off to Abstinence: Unraveling Synthetic Cannabinoid Contamination in Hair Analysis With Headgear Evidence? 结束禁欲:用头饰证据解开头发分析中的合成大麻素污染?
IF 2.6 3区 医学
Drug Testing and Analysis Pub Date : 2026-11-05 DOI: 10.1002/dta.70185
Annette Zschiesche, Yvonne S Jungel, Detlef Thieme, Laura M Huppertz, Merja A Neukamm, Volker Auwärter
{"title":"Caps Off to Abstinence: Unraveling Synthetic Cannabinoid Contamination in Hair Analysis With Headgear Evidence?","authors":"Annette Zschiesche, Yvonne S Jungel, Detlef Thieme, Laura M Huppertz, Merja A Neukamm, Volker Auwärter","doi":"10.1002/dta.70185","DOIUrl":"https://doi.org/10.1002/dta.70185","url":null,"abstract":"<p><p>Hair analysis is widely used to retrospectively monitor long-term drug exposure in forensic toxicology, yet the possibility of external contamination can complicate result interpretation. This challenge applies not only to common drugs of abuse but also to synthetic cannabinoids (SCs), one of the largest groups of new psychoactive substances (NPS) on the European drug market. During abstinence control, a suspect's scalp hair sample taken in August 2023 was found positive for MDMB-4en-PINACA (15 pg/mg) along with several other prevalent SCs, for example, ADB-BUTINACA, EDMB-PINACA, and JWH-210, despite a claimed 2-year abstinence period. A multi-matrix, multi-method analytical approach was applied to the scalp hair, washing solutions, and a cutout of the baseball cap worn during and after the alleged period of SC use, comprising gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QToF-MS) screening and liquid chromatography-tandem mass spectrometry (LC-MS/MS) quantification. The cap extract showed an identical SC profile to the hair sample, with MDMB-4en-PINACA at approximately 22 ng/cm<sup>2</sup>. No SCs introduced to the European market after the claimed beginning of abstinence (end of July 2021) were detected. Nicotine, caffeine, and their metabolites verified cap wearing. Hair analyses in our lab since mid-2021 identified MDMB-4en-PINACA as the most prevalent SC (34.8% of positive samples). Thus, contamination of hair by wearing the cap is assumed to be the cause for the presence of SCs in hair. Laboratories engaged in hair analysis for abstinence testing should be aware that drug detection in hair could also result from external contamination by clothing.</p>","PeriodicalId":160,"journal":{"name":"Drug Testing and Analysis","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149339997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systematic Study on Phosphatidylethanol (PEth) Stability and De Novo Formation in Authentic Whole Blood Samples. 真实全血样品中磷脂酰乙醇(PEth)稳定性及新生形成的系统研究。
IF 2.6 3区 医学
Drug Testing and Analysis Pub Date : 2026-11-04 DOI: 10.1002/dta.70180
Lana Brockbals, Alina Inderbitzin, Thomas Kraemer, Andrea E Steuer
{"title":"Systematic Study on Phosphatidylethanol (PEth) Stability and De Novo Formation in Authentic Whole Blood Samples.","authors":"Lana Brockbals, Alina Inderbitzin, Thomas Kraemer, Andrea E Steuer","doi":"10.1002/dta.70180","DOIUrl":"https://doi.org/10.1002/dta.70180","url":null,"abstract":"<p><p>Phosphatidylethanols (PEth) are a group of abnormal phospholipids that are only formed in the presence of ethanol. Particularly, PEth 16:0/18:1 is a popular marker for ethanol abstinence monitoring in the 2-4 weeks preceding blood collection. While a number of studies previously investigated the long-term stability of PEth 16:0/18:1 in whole blood, they came to conflicting results. An analytical liquid chromatography-tandem-mass spectrometry-based method for the quantification of PEth 16:0/18:1 and 16:0/18:2 was fully validated and used to study the long-term stability (up to 5 months) at different storage conditions (room temperature [RT], 4°C, -20°C, and -80°C) as well as stability during postal transport. PEth 16:0/18:1 was found to be stable until the end of the study period when stored at -20°C and -80°C but only showed acceptable stability for 1 month at 4°C and 7 days at RT. In accordance with previous studies, PEth 16:0/18:2 degraded rapidly during transport and storage at RT. For the first time, PEth de novo formation was investigated using whole blood samples from a controlled drinking experiment with and without the in vivo presence of ethanol (instead of spiked samples or animal experiments). Significant PEth 16:0/18:1 de novo formation when stored at -20°C and RT as early as 14 h after sample collection was found, which crucially highlights the importance of proper sample storage. Storage at -20°C should be prevented due to the potential for rapid de novo formation. Ideally, storage (short- and long-term) at -80°C is preferred for reliable results.</p>","PeriodicalId":160,"journal":{"name":"Drug Testing and Analysis","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149331845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书